Stephen R Davio

Title: The Innovative Contributions of Stephen R. Davio

Introduction

Stephen R. Davio is a notable inventor based in Fairport, NY (US), recognized for his significant contributions to the field of ophthalmic pharmaceuticals. With a total of five patents to his name, Davio has made strides in developing compositions and methods that enhance the treatment of ocular conditions.

Latest Patents

Among his latest patents is a groundbreaking formulation titled "Ophthalmic pharmaceutical compositions and methods of making and using same." This stable ophthalmic pharmaceutical composition is designed for the relief, treatment, control, alleviation, or prevention of various pathological ocular conditions. It comprises a first polymer whose viscosity changes with electrolyte concentration, a second polymer that modifies the viscosity of the first, and an oil. This innovative composition can form a stable oil-in-water emulsion during storage, which separates into distinct phases upon application to the eye, thereby enhancing the stability of the active pharmaceutical ingredient.

Another significant patent is related to "Polymorphs of brimonidine pamoate." This patent describes a polymorph of brimonidine pamoate that exhibits unique characteristics and is included in compositions, devices, or implants aimed at treating elevated intraocular pressure and providing neuroprotection to components of the optic nerve system. These advancements are crucial for preventing progressive degeneration of neurological tissues.

Career Highlights

Stephen R. Davio is currently associated with Bausch & Lomb Incorporated, a leading company in the field of eye health. His work at this esteemed organization has allowed him to focus on innovative solutions that address critical ocular health issues.

Collaborations

Throughout his career, Davio has collaborated with talented individuals such as Hongna Wang and Gregory L. McIntire. These partnerships have contributed to the development of his innovative patents and have fostered a collaborative environment for advancing ophthalmic research.

Conclusion

Stephen R. Davio's contributions to ophthalmic pharmaceuticals through his patents and collaborations highlight his commitment to improving eye health. His innovative work continues to pave the way for advancements in the treatment of ocular conditions.